1. Comparative efficacy of tyrosine kinase inhibitor treatments in the third-line setting, for chronic-phase chronic myelogenous leukemia after failure of second-generation tyrosine kinase inhibitors. Issue 1 (January 2015) Authors: Lipton, J.H.; Bryden, P.; Sidhu, M.K.; Huang, H.; McGarry, L.J.; Lustgarten, S.; Mealing, S.; Woods, B.; Whelan, J.; Hawkins, N. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: 58 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗